GLYTONE ACNE TREATMENT MASK- sulfur cream 
GLYTONE ACNE CLARIFYING TREATMENT MASK- sulfur cream 
Pierre Fabre USA Inc.

----------

GLYTONE Acne Treatment Mask

Drug Facts

Active ingredient

Sulfur 6.4%

Purpose

Acne Treatment

Use  For the treatment of acne.

Warnings

For external use only

Flammable: Keep away from fire or flame

Flammable: Keep away from fire or flame.

Do not use on

  • broken skin
  • large areas of the skin

When using this product

  • apply only to areas with acne
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If eye contact occurs, flush thoroughly with water.

Stop use and ask a doctor

  • if excessive skin irritation develops or increases.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Directions

Other information

Store at room temperature of 68-77° F (20-25° C)

Inactive Ingredients

WATER, BENTONITE, ISOPROPYL ALCOHOL, KAOLIN, ZINC OXIDE, GLYCERIN, CALCIUM OXIDE, COCAMIDE MIPA, FRAGRANCE, METHYLPARABEN, SODIUM LAURYL SULFATE.

Principal Display Panel - 85 g - Glytone Acne Treatment Mask Carton

GLYTONE

Acne

Treatment

Mask

ACNE THERAPY

6.4% SULFUR

NET WT. 85 g / 3 OZ.

AcneTreatmentMask

Principal Display Panel - 85 g - Glytone Acne Clarifying Treatment Mask Carton

GLYTONE

ACNE CLARIFYING TREATMENT MASK

ACNE THERAPY

6.4% SULFUR

1% GLYCOLIC ACID

1% LACTIC ACID

NET WT. 85 G / 3 OZ.

Acne Clarifying Treatment Mask

GLYTONE ACNE TREATMENT MASK 
sulfur cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:64760-710
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR64 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
METHYLPARABEN (UNII: A2I8C7HI9T)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
WATER (UNII: 059QF0KO0R)  
BENTONITE (UNII: A3N5ZCN45C)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
KAOLIN (UNII: 24H4NWX5CO)  
ZINC OXIDE (UNII: SOI2LOH54Z)  
GLYCERIN (UNII: PDC6A3C0OX)  
LIME (CALCIUM OXIDE) (UNII: C7X2M0VVNH)  
COCO MONOISOPROPANOLAMIDE (UNII: 21X4Y0VTB1)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64760-710-011 in 1 CARTON03/14/2018
185 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00603/14/201806/05/2024
GLYTONE ACNE CLARIFYING TREATMENT MASK 
sulfur cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:64760-714
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR64 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
KAOLIN (UNII: 24H4NWX5CO)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
GLYCOLIC ACID (UNII: 0WT12SX38S)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
LACTIC ACID LACTATE, L- (UNII: 26T86KT372)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
MENTHYL LACTATE, (-)- (UNII: 2BF9E65L7I)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
WATER (UNII: 059QF0KO0R)  
BENTONITE (UNII: A3N5ZCN45C)  
GLYCERIN (UNII: PDC6A3C0OX)  
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATE (UNII: D2QHA03458)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
BISABOLOL OXIDE A (UNII: 16AE65F94Y)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
SODIUM GLUCONATE (UNII: R6Q3791S76)  
TROPOLONE (UNII: 7L6DL16P1T)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
GLYCERYL RICINOLEATE (UNII: ZUE0CEL42O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64760-714-011 in 1 CARTON06/23/202310/10/2024
185 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00606/23/202310/10/2024
Labeler - Pierre Fabre USA Inc. (117196928)
Registrant - Pierre Fabre USA Inc. (117196928)

Revised: 5/2024
Document Id: 178e03a2-1f79-d16b-e063-6394a90a2aa1
Set id: af005abb-c516-4e81-bf46-2792723835cc
Version: 6
Effective Time: 20240503
 
Pierre Fabre USA Inc.